Huons Co. Ltd
Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, anti-coagulant, antiviral, central nervous system, antibiotic, well-being, urogenital system, and other ch… Read more
Huons Co. Ltd (243070) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.028x
Based on the latest financial reports, Huons Co. Ltd (243070) has a cash flow conversion efficiency ratio of 0.028x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩10.92 Billion) by net assets (₩395.25 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Huons Co. Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Huons Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Huons Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Huons Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bahnhof AB (publ)
F:3B7
|
0.157x |
|
AIC Mines Limited
PINK:IAUFF
|
0.160x |
|
US Masters Residential Property Fund
PINK:UMRRF
|
-0.013x |
|
Econocom Group SE
F:1E91
|
N/A |
|
Arrow Home Group Co. Ltd. A
SHE:001322
|
-0.009x |
|
DB INC
KO:012030
|
-0.041x |
|
Zhejiang Weigang Technology Co. Ltd. A
SHE:001256
|
0.035x |
|
Paik Kwang Ind
KO:001340
|
0.021x |
Annual Cash Flow Conversion Efficiency for Huons Co. Ltd (2016–2024)
The table below shows the annual cash flow conversion efficiency of Huons Co. Ltd from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩345.97 Billion | ₩52.56 Billion | 0.152x | -3.74% |
| 2023-12-31 | ₩330.41 Billion | ₩52.14 Billion | 0.158x | +39.22% |
| 2022-12-31 | ₩282.46 Billion | ₩32.02 Billion | 0.113x | -45.74% |
| 2021-12-31 | ₩266.09 Billion | ₩55.59 Billion | 0.209x | +7.28% |
| 2020-12-31 | ₩238.80 Billion | ₩46.51 Billion | 0.195x | -10.06% |
| 2019-12-31 | ₩194.52 Billion | ₩42.12 Billion | 0.217x | +69.29% |
| 2018-12-31 | ₩163.27 Billion | ₩20.88 Billion | 0.128x | -48.05% |
| 2017-12-31 | ₩122.69 Billion | ₩30.21 Billion | 0.246x | -46.72% |
| 2016-12-31 | ₩93.88 Billion | ₩43.38 Billion | 0.462x | -- |